Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group

Abstract Second malignant neoplasms (SMN) after primary childhood acute lymphoblastic leukemia (ALL) are rare. Among 1487 ALL patients diagnosed between 1981 and 2010 in Austria, the 10‐year cumulative incidence of an SMN was 1.1% ± 0.3%. There was no difference in the 10‐year incidence of SMNs with...

Full description

Bibliographic Details
Main Authors: Fiona Poyer, Karin Dieckmann, Michael Dworzak, Melanie Tamesberger, Oskar Haas, Neil Jones, Karin Nebral, Stefan Köhrer, Reinhard Moser, Gabriele Kropshofer, Christina Peters, Christian Urban, Georg Mann, Ulrike Pötschger, Andishe Attarbaschi, the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:eJHaem
Subjects:
acute lymphoblastic leukemia
incidence
outcome
radiotherapy
second malignant neoplasms
Online Access:https://doi.org/10.1002/jha2.488

Internet

https://doi.org/10.1002/jha2.488

Similar Items